Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans

Clinical Infectious Diseases

Volumn 29, Issue 4, 1999, Pages 926-928

  Harris, Anthony D ^a,b,c,d   Castro, Julio ^a,b,c   Sheppard, Donald C ^a,b,c   Carmeli, Yehuda ^a,b,c   Samore, Matthew H ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CEPHALOSPORIN DERIVATIVE; FLUCONAZOLE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BLADDER CATHETERIZATION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; COMORBIDITY; CONTROLLED STUDY; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0033509034     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520460     Document Type: Article

References (4)

1. Fidel PL, Vazquez JA, Sobel JD. Candida, glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999;12:80-96.
2. Warren JW. Catheter-associated urinary tract infections. Infect Dis Clin North Am 1997;11:609-22.
3. Platt R, Polk BF, Murdock B, Rosner B. Risk factors for nosocomial urinary tract infection. Am J Epidemiol 1986;124:977-85.
4. Wong-Beringer A, Jacobs RA, Guglielmo J. Treatment of funguria. JAMA 1992;267:2780-5.